First name
F.
Last name
Nai
Errani, F., Nai, F., Bochenkova, E., Herok, M., Invernizzi, A., Bedi, R. K., … Caflisch, A. (2026). Structure-Based Design of Potent Pan-YTHDF Ligands. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02977 (Original work published 2026)
Bobileva, O., Nai, F., Niedrite, S., Mayordomo, L., Leite, I., & Caflisch, A. (2026). Adenosine 5′-Carboxamide-Based Inhibitors of METTL1. ACS Medicinal Chemistry Letters, 17(9), 1941–1947. https://doi.org/10.1021/acsmedchemlett.6c00203 (Original work published)
Ren, L., Zhang, H., Bobileva, O., Nai, F., Bi, H., Chan, A., … Su, R. (2026). Targeting the METTL1/m7G Axis as a Therapeutic Strategy in Myeloid Leukemia. Blood, 147(25), 3069–3085. https://doi.org/10.1182/blood.2025030336 (Original work published)
Invernizzi, A., Nai, F., Bedi, R. K., Vargas-Rosales, P. A., Li, Y., Bochenkova, E., … Caflisch, A. (2025). Discovery of YTHDF2 Ligands by Fragment-Based Design. ACS Bio & Med Chem Au, 5(4), 753–765. https://doi.org/10.1021/acsbiomedchemau.5c00099 (Original work published)
Zálešák, F., Nai, F., Herok, M., Bochenkova, E., Bedi, R. K., Li, Y., … Caflisch, A. (2024). Structure-based design of a potent and selective YTHDC1 ligand. Journal of Medicinal Chemistry, 67(11), 9516-9535. https://doi.org/10.1021/acs.jmedchem.4c00599 (Original work published)
Nai, F., Flores-Espinoza, M., Invernizzi, A., Vargas-Rosales, P. A., Bobileva, O., Herok, M., & Caflisch, A. (2023). Small-molecule inhibitors of the m7G-RNA writer METTL1. ACS Bio & Med Chem Au, 4(2), 100-110. https://doi.org/10.1021/acsbiomedchemau.3c00030 (Original work published)
Nai, F., Nachawati, R., Zálešák, F., Wang, X., Li, Y., & Caflisch, A. (2022). Fragment ligands of the m6A-RNA reader YTHDF2. ACS Medicinal Chemistry Letters, 13(9), 1500-1509. https://doi.org/https://doi.org/10.1021/acsmedchemlett.2c00303
Li, Y., Bedi, R. K., Nai, F., von Roten, V., Dolbois, A., Zálešák, F., … Caflisch, A. (2022). Structure-based design of ligands of the m6A-RNA reader YTHDC1. European Journal of Medicinal Chemistry Reports, 5, 100057. https://doi.org/https://doi.org/10.1016/j.ejmcr.2022.100057